Conquering Complexity: The Coming Revolution in Oncology Biomarker Testing
Despite the advent of targeted therapies and the associated rise in the use of companion and complementary diagnostics, we are only just emerging from the initial exploratory stages of oncology biomarker testing. As will be argued in this paper, we are on the cusp of a much more radical revolution, and the molecular diagnostics landscape is set to change dramatically in the coming decades. It is crucial that any company entering this space prepare for this imminent upheaval and plan their launch strategy accordingly.
What Worries the World?
The everyday concerns of the global population are the focus of one of Ipsos’ flagship global surveys. Each month we ask an online sample of over 18,000 citizens in more than 25 countries1 about the key issues they believe are facing their country, asking them to pick up to three from a diverse array of topics, ranging from unemployment to access to credit.
Reality Check - Drive Growth, by Understanding the Reality of How People Choose Brands
The pace of technological and social change is bewilderingly fast. In the world of brand and communications, we feel this particularly keenly, with the digital revolution transforming the way that brands seek to connect with people.
Brazil Pulse - May 2017
Brazilians continue without confidence in the direction of the country: 93% state that Brazil is in the wrong direction, index that is similar to what we have seen in recent months. This perception reflects the lack of perspectives regarding the political, economic and social stabilization of the country.
The Age of the Algorithm
It is hard to find a major audience measurement service that does not employ statistical wizardry of one sort or another. From simple weighting of survey results to correct for sample imbalances to modelling the audiences to hard-to-measure media, the use of statistics and algorithms is increasing. In this White Paper, Andrew Green and Mario Paic explore some of these techniques.